An Expert Report on Ginger (DB10344): Pharmacological Profile, Clinical Evidence, and Therapeutic Applications

Section 1: Identification, Classification, and Bioactive Constituents

1.1 Substance Identification and Nomenclature

The substance under review is formally identified within the DrugBank database as DB10344, with the generic name Ginger.[1] It is derived from the rhizome (underground stem) of the plant

Zingiber officinale Roscoe, a species with a long history in traditional medicine and culinary practices worldwide.[2] To ensure precise identification across scientific, regulatory, and clinical domains, a comprehensive list of its identifiers is provided below:

• DrugBank Accession Number: DB10344 [1]
• Scientific Name: Zingiber officinale Roscoe [2]
• Chemical Abstract Service (CAS) Numbers: 84696-15-1, 977001-38-9 [4]
• FDA Unique Ingredient Identifier (UNII): IN6Q3S3414, C5529G5JPQ [4]
• European Community (EC) Number: 919-745-6 [4]
• NCI Thesaurus Code: C66725 [4]
• NLM RxNorm Terminology (RXCUI): 899420 [4]
• Common Synonyms: The substance is also known by various common names, including Indian ginger, Shoga, and Zingiberis.[4]

1.2 Regulatory and Pharmacological Classification: A Dual Identity

A critical analysis of the available data reveals that "Ginger" possesses a dual identity within the regulatory and pharmacological landscape. This distinction is fundamental to understanding its applications and mechanisms of action. Failure to differentiate between its two primary classifications can lead to significant misinterpretation of its biological effects.

First, as specifically defined by its DrugBank ID DB10344, Ginger is classified as a "Biotech" product. More precisely, it is categorized as a Non-Standardized Plant Allergenic Extract and a Non-Standardized Food Allergenic Extract.[1] In this context, its designated purpose is for in vivo diagnostic allergenic testing. The physiologic effect underpinning this application is the induction of an immune response, specifically through

Increased Histamine Release and Cell-mediated Immunity.[4] This pro-inflammatory and immune-stimulating action is the intended mechanism for identifying hypersensitivity in patients.

Second, and in stark contrast to its role as a diagnostic allergen, ginger is broadly classified and overwhelmingly studied as a therapeutic agent, typically regulated as an Herbal and Dietary Supplement.[4] In the United States, it holds "Generally Recognised as Safe" (GRAS) status from the Food and Drug Administration (FDA), signifying its long history of safe consumption as a food.[5] In this therapeutic context, its pharmacological effects are primarily anti-inflammatory, anti-emetic, and antioxidant—the direct opposite of the effects sought in allergenic testing. This report will primarily focus on the extensive body of evidence related to this therapeutic identity, while clearly delineating the specific application of DB10344 as a diagnostic tool.

1.3 Key Bioactive Compounds and Phytochemistry

The diverse pharmacological activities of ginger are attributed to a complex mixture of bioactive compounds, primarily non-volatile phenolic compounds and volatile essential oils.[7] The relative concentrations of these compounds can vary significantly based on the preparation of the rhizome (e.g., fresh versus dried), a factor that introduces considerable variability into clinical research and therapeutic outcomes.

Primary Phenolic Compounds: These non-volatile constituents are responsible for ginger's characteristic pungency and are considered the main drivers of its medicinal properties.[3] The major classes include:

• Gingerols: These are the most abundant phenolic compounds in fresh ginger rhizomes, with -gingerol being the principal and most studied representative.[10] Gingerols are recognized for their potent anti-inflammatory, analgesic, antioxidant, and anti-cancer properties.[2]
• Shogaols: These compounds are formed from the dehydration of gingerols during thermal processing or long-term storage.[9] Consequently, dried ginger contains higher concentrations of shogaols, with -shogaol being the most prominent. Shogaols are often more pungent and exhibit more potent anti-inflammatory and anti-cancer activities than their gingerol precursors, making the processing method a critical determinant of the final product's biological activity.[9]
• Zingerone and Paradols: These are minor but important bioactive constituents. Zingerone is typically formed from gingerols through a retro-aldol reaction during cooking or drying, while paradols can be formed from the metabolism of shogaols.[7] Both contribute to the overall antioxidant and anti-inflammatory profile of ginger.[2]

Volatile Oils (Essential Oils): Comprising approximately 1-3% of fresh ginger by weight, these oils are responsible for its distinct aroma.[2] The main constituents are sesquiterpenoids, such as (-)-zingiberene, and monoterpenoids.[2] While their systemic therapeutic effects are less characterized than those of the phenolic compounds, they are integral to the phytochemical profile of the whole plant extract.

The chemical lability of gingerols and their conversion to the more potent shogaols upon processing is a crucial variable. Clinical trials often use different preparations (e.g., fresh root, dried powder, ethanol extract) with unspecified phytochemical profiles. This lack of standardization is a major confounding factor and likely contributes to the high heterogeneity observed in meta-analyses of ginger's efficacy, making direct comparisons between studies challenging.[18]

Section 2: Comprehensive Pharmacological Profile and Mechanisms of Action

The therapeutic effects of Zingiber officinale are not attributable to a single mechanism but rather to the pleiotropic action of its bioactive compounds on a wide array of distinct molecular targets and signaling pathways. This multi-target pharmacology explains its broad spectrum of clinical applications, from gastrointestinal disorders to chronic inflammatory diseases.

2.1 Anti-inflammatory and Analgesic Mechanisms

Ginger's most well-documented pharmacological property is its ability to mitigate inflammation and pain. Its mechanisms are multifaceted, targeting key enzymatic and signaling pathways in the inflammatory cascade.

• Inhibition of Pro-inflammatory Mediators: The bioactive compounds in ginger, particularly -gingerol and -shogaol, directly inhibit the activity of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (LOX) enzymes.[12] These enzymes are critical for the synthesis of pro-inflammatory mediators. By inhibiting COX-2, ginger reduces the production of prostaglandins, which are key drivers of pain, fever, and inflammation. By inhibiting LOX, it reduces the production of leukotrienes, another class of inflammatory mediators. This dual-inhibition mechanism is analogous to that of some nonsteroidal anti-inflammatory drugs (NSAIDs) but may be associated with a more favorable gastrointestinal safety profile.[12]
• Modulation of Inflammatory Signaling Pathways: A central mechanism of ginger's anti-inflammatory action is the suppression of the nuclear factor-kappa B (NF-κB) signaling pathway.[7] NF-κB is a master transcription factor that controls the expression of numerous genes involved in the inflammatory and immune responses. By preventing NF-κB activation, ginger extracts downregulate the production of a host of pro-inflammatory cytokines, including Tumor Necrosis Factor-alpha (TNF-α), Interleukin-1β (IL-1β), and Interleukin-6 (IL-6).[9] This mechanistic action is supported by clinical data from meta-analyses, which confirm that ginger supplementation significantly reduces circulating levels of key inflammatory biomarkers, including C-reactive protein (CRP), high-sensitivity CRP (hs-CRP), and TNF-α.[12]
• Vanilloid Receptor Agonism: Beyond inhibiting inflammatory mediators, ginger compounds also directly modulate pain perception. Gingerols and zingerone have been shown to act as agonists at the transient receptor potential vanilloid 1 (TRPV1) receptor.[20] This receptor is a nociceptor found on sensory neurons that is involved in the detection and signaling of noxious heat and pain. Agonism at this receptor can lead to an initial sensation of pungency or heat, followed by a desensitization period, which contributes to an overall analgesic effect.

2.2 Anti-Emetic and Gastrointestinal Effects

Ginger has been used for centuries as a remedy for nausea and digestive ailments. Modern research has elucidated the specific mechanisms responsible for these effects.

• Serotonin Receptor Antagonism: The primary mechanism underlying ginger's potent anti-emetic effect is believed to be its antagonism of serotonin 5-HT3 receptors located in both the central nervous system and the gastrointestinal tract.[23] Serotonin release in the gut is a key trigger for the vomiting reflex, particularly in the context of chemotherapy and pregnancy. By blocking these receptors, ginger's active compounds can interrupt the signaling cascade that leads to nausea and vomiting. This mechanism is shared with a class of powerful prescription anti-emetic drugs known as setrons (e.g., ondansetron), providing a strong pharmacological basis for ginger's clinical efficacy in managing nausea.[25]
• Gastrointestinal Motility: Ginger also exerts a carminative effect, helping to relieve symptoms of indigestion, bloating, and gas by modulating gastrointestinal motility.[2] It has been shown to accelerate gastric emptying and stimulate antral contractions, which helps propel food through the digestive tract.[27] This prokinetic effect is thought to be mediated, in part, by the inhibition of calcium influx into the smooth muscle cells of the gut wall, which helps to control gastric motility.[5]

2.3 Antioxidant and Immunomodulatory Activity

Ginger possesses significant antioxidant properties that protect cells from damage and can modulate the function of the immune system, suggesting a role in diseases driven by oxidative stress and immune dysregulation.

• Scavenging of Reactive Oxygen Species (ROS): Ginger is a rich source of phenolic antioxidants, including gingerols, shogaols, and zingerone, which can directly neutralize harmful free radicals such as superoxide anions and hydroxyl radicals.[13] This direct scavenging activity helps to prevent lipid peroxidation and reduce oxidative stress. Clinical studies have substantiated this effect, showing that ginger supplementation leads to a reduction in malondialdehyde (MDA), a marker of lipid peroxidation, and an increase in the activity of endogenous antioxidant enzymes like glutathione peroxidase.[18]
• Activation of Endogenous Antioxidant Pathways: Beyond direct scavenging, ginger's antioxidant mechanism involves the activation of the Nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathway.[7] Nrf2 is a transcription factor that regulates the expression of a wide array of protective genes, including those for endogenous antioxidant and detoxification enzymes. By activating this pathway, ginger enhances the body's own cellular defense systems against oxidative stress.
• Immunomodulation and Neutrophil Regulation: Recent research has uncovered a novel and potentially profound mechanism of action for ginger in modulating the immune system. A clinical study demonstrated that daily intake of ginger supplements by healthy individuals boosts intracellular levels of cyclic AMP (cAMP) within neutrophils, a type of white blood cell.[29] Elevated cAMP levels, in turn, inhibit a process called neutrophil extracellular trap (NET) formation, or NETosis. NETosis is a form of neutrophil cell death that releases a web of DNA and proteins to trap pathogens; however, excessive or dysregulated NETosis is a key pathological driver in a number of autoimmune diseases, including lupus, rheumatoid arthritis, and antiphospholipid syndrome. By restraining NETosis, ginger may directly interfere with a fundamental disease mechanism. This finding represents a potential paradigm shift, elevating ginger from a substance used for general symptom relief to a potential disease-modifying agent in certain autoimmune conditions.

2.4 Metabolic and Cardiovascular Mechanisms

A growing body of evidence indicates that ginger exerts beneficial effects on metabolic and cardiovascular health through multiple, synergistic mechanisms.

• Glycemic Control: Ginger has demonstrated significant anti-diabetic properties. It improves glucose uptake into muscle cells by promoting the translocation of glucose transporter type 4 (GLUT4) from the cell's interior to its surface membrane.[23] It also appears to enhance insulin receptor sensitivity, allowing the body to use insulin more effectively.[23] These mechanisms are supported by robust clinical evidence from meta-analyses, which show that ginger supplementation significantly lowers both fasting blood glucose and glycosylated hemoglobin (HbA1c), a marker of long-term blood sugar control, in individuals with Type 2 Diabetes.[14]
• Lipid Metabolism: Ginger positively influences blood lipid profiles. Mechanistic studies suggest it can lower cholesterol by inhibiting HMG-CoA reductase, the same enzyme targeted by statin medications.[23] Furthermore, it increases the expression of LDL receptors on the surface of liver cells and upregulates the CYP7A1 enzyme, which facilitates the conversion of cholesterol into bile acids, thereby promoting cholesterol excretion.[23] Clinical trials confirm these effects, demonstrating that ginger consumption can lead to a significant reduction in total cholesterol, LDL ("bad") cholesterol, and triglycerides, while simultaneously increasing levels of HDL ("good") cholesterol.[2]
• Blood Pressure Regulation: Ginger may contribute to cardiovascular health by helping to regulate blood pressure. Its proposed mechanisms include promoting vasodilation through the regulation of nitric oxide synthase and inhibiting the activity of angiotensin-converting enzyme (ACE), a key target of many prescription antihypertensive drugs.[23]

Section 3: Pharmacokinetics: Absorption, Distribution, Metabolism, and Excretion (ADME)

The clinical effects of ginger are profoundly influenced by the pharmacokinetic properties of its bioactive compounds. A key feature of ginger's pharmacokinetics is the extensive first-pass metabolism of its primary phenolics, which leads to low systemic bioavailability of the parent compounds but high concentrations of their metabolites. This phenomenon presents a "bioavailability paradox," where robust systemic effects are observed despite negligible plasma levels of the presumed active ingredients.

3.1 Absorption and Bioavailability

The phenolic compounds in ginger, such as gingerols and shogaols, are chemically stable in the acidic environment of the stomach and the neutral-to-alkaline environment of the intestines, making them suitable for oral administration.[31] Upon ingestion, they are absorbed from the gastrointestinal tract. However, they are subject to rapid and extensive first-pass metabolism, primarily through glucuronidation and sulfation, which occurs in both the intestinal epithelium and the liver.[11] This metabolic process significantly limits the amount of the free, unchanged compounds that reach systemic circulation, resulting in low oral bioavailability.

3.2 Metabolism and Systemic Exposure

The metabolic fate of ginger's active compounds is central to understanding their biological activity. Human pharmacokinetic studies have consistently shown that after oral administration of a standard ginger extract, the free forms of the most abundant gingerols are often undetectable in plasma.

A key human study involving a 2.0 g oral dose of ginger extract found that free -gingerol and -gingerol were not detected in plasma at any point over a 24-hour period.[10] In contrast, the less abundant free -gingerol and -shogaol were detectable, but only at low peak concentrations (

) of approximately 9.5 ng/mL and 13.6 ng/mL, respectively, occurring about one hour post-dose.[10]

The vast majority of these compounds circulate systemically as glucuronide and sulfate metabolites. The peak plasma concentrations of these conjugated metabolites are orders of magnitude higher than those of the free compounds, typically reaching the high ng/mL to low µg/mL range.[10] This demonstrates that conjugation is the primary metabolic pathway and that the systemic exposure is predominantly to these metabolites, not the parent compounds. This finding has critical implications, suggesting that either the metabolites themselves are bioactive and responsible for ginger's systemic effects, or that the primary site of action for many of ginger's benefits is localized to the gastrointestinal tract, where concentrations of the free compounds are highest before metabolism occurs.

3.3 Distribution and Elimination

Following absorption and metabolism, ginger's constituents and their metabolites are distributed throughout the body before being eliminated. Evidence suggests that the compounds tend to accumulate in the gastrointestinal tract, which aligns with ginger's pronounced effects on nausea and digestive function.[13] Studies have found only very low concentrations of metabolites in colon tissues, indicating that systemic distribution to peripheral tissues may be limited.[10]

Elimination of ginger compounds and their metabolites is relatively rapid. The plasma elimination half-lives () for both the parent phenolics and their primary glucuronide and sulfate conjugates are estimated to be between 1 and 3 hours in humans.[10] This rapid clearance means that no significant accumulation of the compounds or their metabolites occurs in either plasma or colon tissue, even with repeated daily dosing. The primary routes of excretion for the metabolites are through the bile into the feces and through the kidneys into the urine.[11]

3.4 Human Pharmacokinetic Parameters

To provide a clear, quantitative summary of the pharmacokinetic profile of ginger's main active compounds, the following table consolidates data from human studies following a 2.0 g oral dose of ginger extract. The data starkly illustrates the low systemic exposure to free compounds and the predominance of conjugated metabolites.

Table 3.1: Pharmacokinetic Parameters of Ginger Phenolics and Their Metabolites in Human Plasma After a 2.0g Oral Dose of Ginger Extract

Analyte	(µg/mL)	(h)	(h)	(µg·h/mL)
-Gingerol (Free)	N/A	N/A	N/A	N/A
-Gingerol Glucuronide
-Gingerol Sulfate
-Gingerol (Free)	N/A	N/A	N/A	N/A
-Gingerol Glucuronide
-Gingerol Sulfate
-Gingerol (Free)
-Gingerol Glucuronide
-Gingerol Sulfate
-Shogaol (Free)
-Shogaol Glucuronide
-Shogaol Sulfate
N/A: Not Applicable, as the compound was not detected in plasma. Data is presented as mean ± standard deviation. Data compiled from.10

Section 4: Clinical Evidence and Therapeutic Applications

The clinical utility of ginger spans a wide range of applications, from its specific, regulated use as a diagnostic allergen to its widespread use as a therapeutic supplement for various conditions. The strength of the clinical evidence varies significantly by indication, creating a hierarchy of uses from well-established to investigational.

4.1 Approved Indication of DB10344: Allergenic Testing

The specific entity associated with DrugBank ID DB10344 is a non-standardized allergenic extract of ginger intended for diagnostic use.[1]

• Indication: The extract is used in allergenic testing to determine if an individual has a Type I hypersensitivity (allergy) to ginger.[1]
• Formulation and Administration: It is supplied as an injectable solution, typically in concentrations of 0.1 g/1mL or 0.05 g/1mL, for intradermal, percutaneous, or subcutaneous administration by a healthcare professional.[1]
• Mechanism of Action: In this context, the extract is designed to provoke a localized immune response in susceptible individuals. The mechanism involves triggering mast cell degranulation and inducing increased histamine release and cell-mediated immunity at the site of injection, leading to a characteristic wheal-and-flare reaction that indicates a positive allergic response.[4]

4.2 Efficacy in Gastrointestinal Disorders

Ginger's most robust clinical evidence lies in its efficacy for managing nausea and vomiting from various causes, as well as other functional gastrointestinal complaints.

• Nausea and Vomiting:
• Pregnancy-Related Nausea (Morning Sickness): A substantial body of evidence from multiple meta-analyses and randomized controlled trials (RCTs) confirms that ginger is a safe and effective treatment for alleviating the nausea of pregnancy.[5] Typical doses range from 500 mg to 1,500 mg daily in divided doses. It is considered a first-line non-pharmacological option for this indication.[27]
• Chemotherapy-Induced Nausea and Vomiting (CINV): Several clinical trials have demonstrated that ginger can serve as a valuable and safe adjunct to standard anti-emetic drug regimens for patients undergoing chemotherapy. It has been shown to reduce the severity of both acute and delayed CINV, with particularly notable evidence in breast cancer patients.[5]
• Post-Operative Nausea and Vomiting (PONV) and Motion Sickness: The evidence for these indications is less consistent. While some studies have shown a benefit, others have found no significant effect compared to placebo, suggesting that its efficacy may be less reliable for PONV and motion sickness than for pregnancy-related or chemotherapy-induced nausea.[5]
• Functional Dyspepsia: Recent clinical trials have provided strong evidence for ginger's utility in managing functional dyspepsia (chronic indigestion). A 12-week, double-blind, placebo-controlled RCT found that a daily dose of 480 mg of steamed ginger extract significantly improved a range of gastrointestinal symptoms, including abdominal pain, indigestion, constipation, and reflux, compared to placebo.[35] Another 8-week trial using 1080 mg of ginger daily in patients with functional dyspepsia confirmed its excellent tolerability.[36]

4.3 Efficacy in Pain and Inflammatory Conditions

Ginger's anti-inflammatory and analgesic properties have been validated in numerous clinical trials for chronic pain conditions.

• Osteoarthritis (OA): There is compelling evidence from multiple RCTs and meta-analyses supporting the use of both oral and topical ginger for managing the symptoms of osteoarthritis, particularly of the knee.[13] Studies have consistently shown that ginger supplementation leads to a significant reduction in pain and stiffness. Some research suggests its efficacy is comparable to that of NSAIDs like ibuprofen, but with a more favorable side effect profile, especially concerning the gastrointestinal tract.[12]
• Dysmenorrhea (Menstrual Pain): Several clinical trials have found ginger to be highly effective in alleviating primary dysmenorrhea. The evidence suggests that ginger is as effective as common NSAIDs, including mefenamic acid and ibuprofen, for pain relief during menstruation.[14]
• Delayed Onset Muscle Soreness (DOMS): Research on ginger for exercise-induced muscle soreness indicates that daily supplementation may not reduce the immediate sensation of pain but can help accelerate the recovery of muscle strength and function following strenuous exercise.[20]
• Rheumatoid Arthritis (RA) and Psoriasis: While much of the evidence comes from preclinical models, some clinical studies support ginger's potential in managing inflammatory autoimmune conditions like RA and psoriasis. Its efficacy is linked to its ability to inhibit the NF-κB pathway and reduce oxidative stress.[12]

4.4 Efficacy in Metabolic and Autoimmune Diseases

The clinical applications of ginger are expanding into the management of chronic metabolic and autoimmune diseases.

• Type 2 Diabetes Mellitus (T2DM): Meta-analyses of RCTs have provided strong evidence that ginger supplementation, typically in doses of 1-3 g per day, can significantly improve glycemic control in patients with T2DM. It has been shown to lower both fasting blood glucose levels and HbA1c, indicating improved long-term management of the disease.[14]
• Hyperlipidemia: Clinical evidence supports ginger's role as a lipid-lowering agent. Studies have shown that ginger supplementation can lead to a statistically significant reduction in circulating levels of LDL cholesterol and triglycerides, along with an increase in beneficial HDL cholesterol.[14]
• Autoimmune Disease: While clinical trials in patients are still forthcoming, a landmark mechanistic study in healthy human volunteers has provided a strong rationale for ginger's use in autoimmune diseases. The study found that daily ginger supplementation inhibits NETosis, a fundamental pathological process implicated in systemic lupus erythematosus, rheumatoid arthritis, and antiphospholipid syndrome.[29] This positions ginger as a promising candidate for future clinical trials as a disease-modifying agent in these conditions.

4.5 Investigational Uses and Ongoing Research

The broad pharmacological profile of ginger has prompted a wide range of clinical investigations into new therapeutic areas.

• Dermatology: A completed Phase 1 clinical trial has explored the efficacy of a homeopathic preparation of Zingiber Officinalis for the treatment of acne vulgaris.[38]
• Dentistry: A completed Phase 2 trial compared the efficacy of ginger to glucosamine sulphate as an adjunct in non-surgical periodontal therapy.[39] Furthermore, an ongoing RCT is actively evaluating the analgesic efficacy of 500 mg ginger powder capsules for managing intra-operative and post-endodontic pain in patients with symptomatic irreversible pulpitis.[21]
• Metabolism and Weight Management: A completed clinical trial investigated the thermogenic (metabolism-boosting) and energy expenditure effects of ginger extract in healthy women, with results suggesting an acute effect on energy expenditure.[41]
• Infectious Disease: A recent RCT evaluated high-dose ginger (3000 mg/day) in outpatients with mild COVID-19. While it did not improve viral clearance or primary clinical symptoms, the treatment was found to be safe and was associated with a significant reduction in pulmonary infiltrate seen on imaging, suggesting a potential role in mitigating lung inflammation.[37]

The body of clinical evidence for ginger is robust in certain areas but nascent in others. For indications like pregnancy-related nausea, dysmenorrhea, and osteoarthritis pain, the evidence is strong and supported by multiple high-quality studies and meta-analyses. For metabolic conditions like T2DM, the evidence is promising but may require larger, longer-term trials for confirmation. For emerging areas like autoimmune disease, the mechanistic rationale is compelling, but patient-centered clinical data is still needed. This stratification of evidence is essential for making responsible clinical recommendations.

Section 5: Safety Profile, Toxicology, and Drug Interactions

Ginger is widely regarded as a safe substance, particularly when consumed in amounts typical of culinary use or standard dietary supplementation. However, its safety is dose-dependent, and its use requires caution in certain patient populations and with concurrent medications due to its pharmacological activities.

5.1 General Safety and Tolerability

Zingiber officinale is designated as "Generally Recognized as Safe" (GRAS) by the U.S. FDA, a status reflecting its long history of safe use in the food supply.[5] This favorable safety profile is corroborated by numerous clinical trials where ginger has been shown to be well-tolerated. In many studies, the incidence of adverse events in groups receiving ginger was comparable to or even lower than that in placebo groups or groups receiving standard comparator drugs.[4] Daily doses of up to 2.0 grams of ginger extract have demonstrated very low levels of toxicity in human trials.[11] Most expert sources recommend a general upper limit of 4 grams of ginger per day to minimize the risk of side effects.[42]

5.2 Adverse Effects

The adverse effects associated with ginger are generally mild, transient, and primarily related to the gastrointestinal system. The likelihood of experiencing side effects increases with higher doses, particularly those exceeding 5 grams per day.[43]

• Common Side Effects: The most frequently reported adverse events include heartburn (acid reflux), abdominal discomfort, bloating, flatulence, dyspepsia, diarrhea, and irritation of the mouth and throat.[5]
• Rare Side Effects: Hypersensitivity or allergic reactions to ginger are uncommon but can occur, typically manifesting as a skin rash (contact dermatitis) or hives.[5] Extremely rare adverse events noted in isolated case reports include fainting, subacute thyroiditis, and painful urination, but these are not considered common or established side effects.[44]

5.3 Hepatotoxicity Assessment

A specific evaluation of liver safety is critical for any herbal supplement. The evidence for ginger in this regard is overwhelmingly reassuring.

• In a comprehensive review of over 100 clinical trials, ginger has not been linked to elevations in serum aminotransferase levels or to any instances of clinically apparent liver injury.[4]
• The National Institute of Diabetes and Digestive and Kidney Diseases' LiverTox database, a leading resource on drug-induced liver injury, assigns ginger a likelihood score of "E," which corresponds to an "unlikely cause of clinically apparent liver injury".[4]
• There is a single case report from Japan describing an elderly woman who developed acute hepatocellular injury after taking a commercial botanical product that contained ginger for two months. However, the product's purity was not characterized, and it may have contained other constituents or contaminants, making a causal link to ginger uncertain.[4] Thus, while thorough assessment has been limited, ginger is not considered to be hepatotoxic.

5.4 Contraindications, Precautions, and Drug Interactions

Despite its general safety, ginger's distinct pharmacological effects necessitate caution in specific clinical scenarios due to the potential for adverse interactions.

• Bleeding Disorders and Anticoagulant/Antiplatelet Therapy: Ginger contains salicylates and has demonstrated antiplatelet activity by inhibiting thromboxane synthesis.[2] This can potentiate the effects of anticoagulant drugs (e.g., warfarin) and antiplatelet agents (e.g., aspirin, clopidogrel), theoretically increasing the risk of bleeding. Therefore, it should be used with caution in individuals with bleeding disorders or those on these medications.[4]
• Gallstone Disease: Ginger stimulates the secretion of bile acids, which can be beneficial for digestion but may exacerbate symptoms or complications in individuals with pre-existing gallstones. It is generally recommended that patients with gallstone disease avoid ginger supplements.[4]
• Cardiovascular Conditions and Antihypertensive Medications: In high doses, ginger can lower blood pressure and, in rare instances, may cause cardiac arrhythmia.[4] Patients with heart conditions or those taking antihypertensive medications should use ginger with caution and monitor for potential hypotension or other cardiac effects.[43]
• Diabetes and Antidiabetic Medications: Due to its established blood glucose-lowering effects, individuals with diabetes who are taking insulin or oral hypoglycemic agents should monitor their blood sugar levels closely when using ginger to prevent episodes of hypoglycemia.[43]
• Pregnancy: While ginger is considered safe and effective for treating morning sickness at recommended doses (typically under 1.5 grams per day), some theoretical concerns have been raised about the safety of very high doses during pregnancy.[26] Pregnant individuals should always consult with their healthcare provider before using ginger supplements.[6]

Section 6: Commercial Formulations, Products, and Dosage

The commercial availability of ginger ranges from highly specific, regulated medical products to a vast and largely unregulated market of dietary supplements. This diversity presents both opportunities and challenges for its clinical application.

6.1 Formulations of DB10344

The specific product identified as DrugBank ID DB10344 is an allergenic extract intended for diagnostic purposes. Its formulations are standardized for medical use:

• It is available as an injectable solution for intradermal, percutaneous, and subcutaneous administration.[1]
• Standard strengths include 0.1 g/1mL and 0.05 g/1mL.[1]
• Known labellers for these diagnostic products include Nelco Laboratories, Inc. and Greer Laboratories, Inc..[1]

6.2 General Therapeutic Formulations

In contrast to the specific diagnostic extract, therapeutic ginger is available in a multitude of over-the-counter (OTC) forms. This market is characterized by a significant lack of standardization, which poses a major challenge for consumers and clinicians seeking reliable and consistent effects.

• Oral Formulations: Common forms for internal use include dried powder in capsules or tablets, crystallized ginger, liquid extracts, and teas made from fresh or dried root.[27]
• Topical Formulations: Ginger is also a frequent ingredient in a wide array of multi-component topical products, such as creams, shampoos, and transdermal patches. These are often marketed with claims related to pain relief, slimming, or hair care.[1]

The central issue with these therapeutic products is the variability in their bioactive compound profile. As established, the processing method (e.g., drying, extraction solvent) dramatically alters the ratio of gingerols to the more potent shogaols.[9] Most commercial supplement labels do not specify the content of these key active compounds, making it nearly impossible for a consumer to know if a product matches the composition of those used in successful clinical trials. This "standardization crisis" is a significant barrier to the widespread acceptance of ginger as an evidence-based medicine and is a likely contributor to the heterogeneity seen in clinical trial meta-analyses.[19]

6.3 Clinically Studied Dosages

To guide evidence-based use, it is helpful to refer to the dosages that have been validated in clinical trials for specific therapeutic effects.

• Nausea and Vomiting: Effective dosages typically range from 500 mg to 1,500 mg of dried ginger powder per day, often administered in divided doses.[18]
• Pain, Inflammation, and Metabolic Conditions: For indications such as osteoarthritis, dysmenorrhea, and Type 2 Diabetes, most clinical trials have used daily doses in the range of 1 gram to 3 grams of powdered ginger or an equivalent extract.[14]
• Functional Dyspepsia: Successful trials have employed doses ranging from 480 mg of a steamed ginger extract to 1080 mg of ginger powder daily.[35]
• Immunomodulation (NETosis Inhibition): The key mechanistic study that demonstrated inhibition of NETosis in neutrophils used a daily supplement providing 20 mg of total gingerols.[29]

Section 7: Synthesis and Expert Recommendations

7.1 Integrated Analysis

Zingiber officinale is a complex botanical agent with a compelling and expanding body of scientific evidence supporting its therapeutic use. The analysis of its pharmacology, pharmacokinetics, and clinical data reveals several critical themes. First, it possesses a dual identity: the specific DrugBank entity DB10344 is a pro-inflammatory allergenic extract for diagnostics, which stands in stark contrast to the anti-inflammatory and anti-emetic properties of ginger used as a therapeutic supplement. Second, its clinical efficacy is driven by a pleiotropic, multi-target pharmacology, where a suite of bioactive compounds (gingerols, shogaols) acts on numerous distinct pathways (COX-2, NF-κB, 5-HT3, Nrf2), explaining its broad utility. Third, the "bioavailability paradox"—whereby robust systemic effects are observed despite negligible plasma levels of free parent compounds—highlights the critical importance of its active metabolites or its potent local action within the gastrointestinal tract.

The clinical evidence for ginger can be stratified. Its efficacy is well-established for pregnancy-related nausea, dysmenorrhea, and osteoarthritis pain. The evidence is promising and growing for Type 2 Diabetes, hyperlipidemia, and chemotherapy-induced nausea. Finally, emerging mechanistic data, particularly the inhibition of NETosis, positions ginger as a highly promising agent for future investigation in autoimmune diseases, representing a potential shift from symptomatic treatment to disease modification. However, this potential is tempered by a significant "standardization crisis" in the commercial supplement market, which creates uncertainty and likely contributes to inconsistent clinical outcomes. Its safety profile is excellent at standard doses, but its use requires careful consideration of its dose-dependent side effects and potential interactions with anticoagulant, antiplatelet, and antidiabetic medications.

7.2 Gaps in Current Research

Despite the wealth of data, significant gaps remain in the scientific literature that hinder the full realization of ginger's therapeutic potential.

• Lack of Standardization: The most critical deficiency is the widespread use of non-standardized and poorly characterized ginger preparations in clinical trials. This makes it difficult to establish clear dose-response relationships and to replicate findings across studies.[16]
• Small and Short-Term Trials: Many published RCTs are limited by small sample sizes (often fewer than 100 participants) and short treatment durations. Such studies may be underpowered to detect modest but clinically meaningful effects and cannot assess long-term efficacy or safety.[48]
• Under-reporting of Results: A systematic analysis of the ClinicalTrials.gov database reveals a low rate of reporting for completed studies, creating a potential publication bias that may skew the overall perception of ginger's efficacy.[49]
• Pharmacology of Metabolites: The "bioavailability paradox" underscores a major gap in our understanding. While we know that gingerols and shogaols are extensively converted to glucuronide and sulfate conjugates, the specific biological activities of these major metabolites remain largely uninvestigated.

7.3 Recommendations for Clinical Practice and Future Research

Based on this comprehensive analysis, the following recommendations are proposed:

For Clinical Practice:

1. Evidence-Based Recommendations: Clinicians can confidently recommend ginger as a complementary therapy for its well-supported indications: pregnancy-related nausea, primary dysmenorrhea, and osteoarthritis. The recommended dosages should align with those used in successful clinical trials (e.g., 1-1.5 g/day).
2. Vigilance for Contraindications and Interactions: It is imperative to screen patients for contraindications, particularly bleeding disorders and gallstone disease. Clinicians must counsel patients on the potential for interactions with anticoagulant, antiplatelet, antihypertensive, and antidiabetic medications.
3. Product Selection: Advise patients to use products from reputable manufacturers that ideally provide information on standardization or the concentration of active compounds (e.g., gingerols).

For Future Research:

1. Prioritize Standardization: Future clinical trials must utilize standardized ginger extracts with clearly defined and quantified phytochemical profiles, specifying the content of key bioactive compounds like -gingerol and -shogaol. This is the single most important step toward generating reliable and reproducible clinical data.
2. Conduct Large-Scale, Long-Term RCTs: There is a pressing need for larger, well-designed, and longer-term randomized controlled trials to definitively establish the efficacy and safety of ginger in its most promising therapeutic areas, including Type 2 Diabetes, hyperlipidemia, and as an adjunct in cancer care.
3. Investigate Emerging Mechanisms: The groundbreaking finding on NETosis inhibition should be a top priority for further research. Clinical trials in patients with lupus, rheumatoid arthritis, and other neutrophil-driven autoimmune diseases are strongly warranted to determine if this mechanistic effect translates into clinical benefit.
4. Elucidate Metabolite Pharmacology: Basic and clinical pharmacology studies should be designed to isolate the major glucuronide and sulfate metabolites of gingerols and shogaols and systematically evaluate their biological activities (e.g., anti-inflammatory, anti-emetic). This is essential for resolving the bioavailability paradox and fully understanding how ginger exerts its systemic effects.

Works cited

1. Ginger: Uses, Interactions, Mechanism of Action | DrugBank Online, accessed October 6, 2025, https://go.drugbank.com/drugs/DB10344
2. (PDF) Zingiber officinale Roscoe (pharmacological activity) - ResearchGate, accessed October 6, 2025, https://www.researchgate.net/publication/265990258_Zingiber_officinale_Roscoe_pharmacological_activity
3. Pharmacokinetics and Tissue Distribution of Gingerols and Shogaols from Ginger (Zingiber officinale Rosc.) in Rats by UPLC–Q-Exactive–HRMS - MDPI, accessed October 6, 2025, https://www.mdpi.com/1420-3049/24/3/512
4. Ginger - PubChem, accessed October 6, 2025, https://pubchem.ncbi.nlm.nih.gov/compound/Ginger
5. Ginger - LiverTox - NCBI Bookshelf, accessed October 6, 2025, https://www.ncbi.nlm.nih.gov/books/NBK600585/
6. Annex A - Information on ginger | Committee on Toxicity - Food Standards Agency, accessed October 6, 2025, https://cot.food.gov.uk/Annex%20A%20-%20Information%20on%20ginger
7. A critical review of Ginger's (Zingiber officinale) antioxidant, anti-inflammatory, and immunomodulatory activities - PMC - PubMed Central, accessed October 6, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC11187345/
8. A critical review of Ginger's (Zingiber officinale) antioxidant, anti-inflammatory, and immunomodulatory activities - Frontiers, accessed October 6, 2025, https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2024.1364836/full
9. The “root” causes behind the anti-inflammatory actions of ginger compounds in immune cells - Frontiers, accessed October 6, 2025, https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1400956/full
10. Examination of the Pharmacokinetics of Active Ingredients of Ginger in Humans - PMC, accessed October 6, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC3160151/
11. Pharmacokinetics of 6-Gingerol, 8-Gingerol, 10-Gingerol, and 6-Shogaol and Conjugate Metabolites in Healthy Human Subjects - AACR Journals, accessed October 6, 2025, https://aacrjournals.org/cebp/article-pdf/17/8/1930/2267857/1930.pdf
12. Anti-Inflammatory Effects of Zingiber officinale: A Comprehensive Review of Its Bioactive Compounds and Therapeutic Potential - medtigo Journal, accessed October 6, 2025, https://journal.medtigo.com/anti-inflammatory-effects-of-zingiber-officinale-a-comprehensive-review-of-its-bioactive-compounds-and-therapeutic-potential/
13. Ginger Root - StatPearls - NCBI Bookshelf, accessed October 6, 2025, https://www.ncbi.nlm.nih.gov/books/NBK565886/
14. Ginger Health Benefits: Digestion, Nausea, and More - Healthline, accessed October 6, 2025, https://www.healthline.com/nutrition/11-proven-benefits-of-ginger
15. Effect of Ginger on Inflammatory Diseases - MDPI, accessed October 6, 2025, https://www.mdpi.com/1420-3049/27/21/7223
16. Zingiber Officinale Roscoe: The Antiarthritic Potential of a Popular Spice—Preclinical and Clinical Evidence - MDPI, accessed October 6, 2025, https://www.mdpi.com/2072-6643/16/5/741
17. Pharmacokinetics of 6-, 8-, 10-Gingerols and 6-Shogaol and Conjugate Metabolites in Healthy Human Subjects, accessed October 6, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC2676573/
18. Pharmacological properties of ginger (Zingiber officinale): what do meta-analyses say? a systematic review - Frontiers, accessed October 6, 2025, https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1619655/full
19. Pharmacological properties of ginger (Zingiber officinale): what do meta-analyses say? a systematic review - PubMed Central, accessed October 6, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC12343617/
20. Clinical trials on pain lowering effect of ginger: A narrative review - PMC - PubMed Central, accessed October 6, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC7754412/
21. Study Details | NCT06439212 | the Efficacy of Ginger Powder as an Analgesic for Intraoperative and Post- Endodontic Pain Management | ClinicalTrials.gov, accessed October 6, 2025, https://clinicaltrials.gov/study/NCT06439212
22. Pharmacological properties of ginger (Zingiber officinale): what do meta-analyses say? a systematic review - PubMed, accessed October 6, 2025, https://pubmed.ncbi.nlm.nih.gov/40808693/
23. Therapeutic health effects of ginger (Zingiber officinale): updated narrative review exploring the mechanisms of action - Oxford Academic, accessed October 6, 2025, https://academic.oup.com/nutritionreviews/article/81/9/1213/6998109
24. www.ncbi.nlm.nih.gov, accessed October 6, 2025, https://www.ncbi.nlm.nih.gov/books/NBK565886/#:~:text=The%20exact%20mechanism%20by%20which,known%20to%20provide%20nausea%20relief.
25. Efficacy and Safety of Ginger on the Side Effects of Chemotherapy in Breast Cancer Patients: Systematic Review and Meta-Analysis - MDPI, accessed October 6, 2025, https://www.mdpi.com/1422-0067/23/19/11267
26. Ginger: Uses, benefits, and nutrition - Medical News Today, accessed October 6, 2025, https://www.medicalnewstoday.com/articles/265990
27. Ginger - Content - Health Encyclopedia - University of Rochester ..., accessed October 6, 2025, https://www.urmc.rochester.edu/encyclopedia/content?contenttypeid=19&contentid=Ginger
28. Health Benefits of Ginger - Cleveland Clinic Health Essentials, accessed October 6, 2025, https://health.clevelandclinic.org/ginger-health-benefits
29. New Research Adds Evidence to the Benefits of Ginger Supplements for Treating Autoimmune Diseases - CU Anschutz newsroom, accessed October 6, 2025, https://news.cuanschutz.edu/news-stories/new-research-adds-evidence-to-the-benefits-of-ginger-supplements-for-treating-autoimmune-diseases
30. Why you should consider adding ginger to your diet - UCLA Health, accessed October 6, 2025, https://www.uclahealth.org/news/article/why-you-should-consider-adding-ginger-to-your-diet
31. Absorption, Metabolic Stability, and Pharmacokinetics of Ginger Phytochemicals - MDPI, accessed October 6, 2025, https://www.mdpi.com/1420-3049/22/4/553
32. Examination of the Pharmacokinetics of Active Ingredients of Ginger ..., accessed October 6, 2025, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3160151/
33. Ginger - DrugBank, accessed October 6, 2025, https://go.drugbank.com/unearth/q?searcher=drugs&utf8=%E2%9C%93&query=feverfew+AND+Ginger&search_type=drugs&button=
34. Ginger: Usefulness and Safety | NCCIH, accessed October 6, 2025, https://www.nccih.nih.gov/health/ginger
35. Efficacy and safety of steamed ginger extract for gastric health: a randomized, double-blind, placebo-controlled multi-center clinical trial - RSC Publishing, accessed October 6, 2025, https://pubs.rsc.org/en/content/articlehtml/2025/fo/d5fo01172h
36. Evaluation of Adverse Effects and Tolerability of Dietary Ginger Supplementation in Patients With Functional Dyspepsia - PubMed, accessed October 6, 2025, https://pubmed.ncbi.nlm.nih.gov/40474983/
37. The efficacy and safety of ginger (Zingiber officinale) rhizome extract in outpatients with COVID-19: A randomized double-blind placebo-control clinical trial | Request PDF - ResearchGate, accessed October 6, 2025, https://www.researchgate.net/publication/381092189_The_efficacy_and_safety_of_ginger_Zingiber_officinale_rhizome_extract_in_outpatients_with_COVID-19_A_randomized_double-blind_placebo-control_clinical_trial
38. Ginger Completed Phase 1 Trials for Acne Vulgaris Treatment | DrugBank Online, accessed October 6, 2025, https://go.drugbank.com/drugs/DB10344/clinical_trials?conditions=DBCOND0029828&phase=1&purpose=treatment&status=completed
39. Ginger Completed Phase 2 Trials for Pocket, Periodontal Treatment | DrugBank Online, accessed October 6, 2025, https://go.drugbank.com/drugs/DB10344/clinical_trials?conditions=DBCOND0130266&phase=2&purpose=treatment&status=completed
40. Glucosamine Completed Phase 2 Trials for Pocket, Periodontal Treatment - DrugBank, accessed October 6, 2025, https://go.drugbank.com/drugs/DB01296/clinical_trials?conditions=DBCOND0130266&phase=2&purpose=treatment&status=completed
41. Study Details | NCT03089593 | Thermogenic Effect of Ginger - ClinicalTrials.gov, accessed October 6, 2025, https://clinicaltrials.gov/study/NCT03089593
42. Ginger for diarrhea: Research, dosage, and side effects - Medical News Today, accessed October 6, 2025, https://www.medicalnewstoday.com/articles/320546
43. Ginger: Health Benefits & Side-Effects - WebMD, accessed October 6, 2025, https://www.webmd.com/vitamins-and-supplements/ginger-uses-and-risks
44. 9 Side Effects of Ginger - Verywell Health, accessed October 6, 2025, https://www.verywellhealth.com/side-effects-of-ginger-11800235
45. allergylosangeles.com, accessed October 6, 2025, https://allergylosangeles.com/allergy-blog/ginger-allergy-symptoms-diagnosis-treatment/#:~:text=The%20symptoms%20of%20ginger%20allergy,may%20occur%20after%20consuming%20ginger.
46. Ginger Tea: Does It Have Any Bad Side Effects? - Healthline, accessed October 6, 2025, https://www.healthline.com/health/food-nutrition/ginger-tea-side-effects
47. Be careful with ginger! - Tastea, accessed October 6, 2025, https://www.tastea.eu/en/blogs/blog/be-careful-with-ginger/
48. Ginger on Human Health: A Comprehensive Systematic Review of 109 Randomized Controlled Trials - PMC, accessed October 6, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC7019938/
49. The Clinical Research on Ginger (Zingiber officinale): Insights from ClinicalTrials.gov analysis - Thieme Connect, accessed October 6, 2025, https://www.thieme-connect.com/products/ejournals/abstract/10.1055/a-2357-7064